AHL
AARD

Abel Hall LLC’s Aardvark Therapeutics AARD Stock Holding History

Abel Hall LLC’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58K Buy
+10,066
New +$47K 0.01% 888

Other funds holding AARD

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM

Abel Hall LLC's AARD Position: Q2 2026 in Review

Abel Hall LLC opened a new position in Aardvark Therapeutics (AARD) in Q2 2026: 10,066 shares worth $58K. The stake represents 0.01% of the portfolio and ranks #888 among its holdings.

12 funds tracked by Wall St. Rank hold AARD as of Q2 2026.

  • Abel Hall LLC held 10,066 shares of Aardvark Therapeutics worth $58K as of Q2 2026.
  • Aardvark Therapeutics was a new Abel Hall LLC position in Q2 2026.
  • Aardvark Therapeutics made up 0.01% of Abel Hall LLC's portfolio in Q2 2026, its #888 holding.
  • 12 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.